Topelia Therapeutics
  • Home
    • Mission
    • Team
    • Regulations
  • Clinical Trials
  • News
  • Contact Us
    • Home
    • ABOUT US
      • Mission
      • Team
      • Regulations
    • Clinical Trials
    • News
    • Contact Us

Topelia Therapeutics

  • Home
  • Clinical Trials
  • News
  • Contact Us

clinical trials

COVID-19 Prophylaxis

A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for Prevention of COVID-19 Infection

This is a Phase II interventional study testing whether treatment with hydroxychloroquine, Vitamin C, Vitamin D, and Zinc can prevent infection with COVID-19. The study will last 24 weeks.

COVID-19 Treatment

A Study of Quintuple Therapy to Treat COVID-19 Infection (HAZCpaC) 

This Phase II interventional study will test the efficacy of quintuple therapy in the treatment of patients with COVID-19 infection). The study will last 24 weeks.


A Study of ResCure™ to Treat COVID-19 Infection 

This is a Phase I open-label interventional study which will test the efficacy of ResCure™ in the treatment of patients with COVID-19 infection.


Trial of Combination Therapy to Treat COVID-19 Infection

In this trial patients will be treated with either a combination of therapies (Ivermectin, Doxycycline Hcl, Zinc, Vitamin D3, Vitamin C) to treat COVID-19 or a placebo. Treatment will last 10 days, and patients will be followed for 6 months.


A Study of Combination Therapies to Treat COVID-19 Infection

This study seeks to determine whether dual therapy or quadruple therapy is more effective in treating COVID-19.


A Study of Quintuple Therapy to Treat COVID-19 Infection (HAZCpaC)

This Phase II interventional study will test the efficacy of quintuple therapy (Hydroxychloroquine, Azithromycin, Vitamin C, Vitamin D, and Zinc) in the treatment of patients with COVID-19 infection). The study will last 24 weeks.

Find out more
  • Contact Us

Copyright © 2020 Topelia Therapeutics - All Rights Reserved.